Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $5.90 | Prev. Close $5.95 | Circuit Range N/A |
Day Range $5.71 - $5.90 | Year Range $0.05 - $7.04 | Volume 409 |
Average Traded $5.80 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-May-26 | $5.90 | $5.71 | +0.00% |
21-May-26 | $5.90 | $5.71 | -4.03% |
20-May-26 | $5.83 | $5.95 | +2.15% |
19-May-26 | $6.22 | $5.83 | -13.19% |
18-May-26 | $5.77 | $6.71 | +14.12% |
15-May-26 | $5.59 | $5.88 | +5.00% |
14-May-26 | $5.24 | $5.60 | +10.89% |